Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells
BIOLOGICAL
2 trials
Sponsors
Sun Yat-sen University
, Second Affiliated Hospital of Guangzhou Medical University
Conditions
Non Small Cell Lung Cancer
Early Phase 1
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC
Recruiting
NCT05060796
Second Affiliated Hospital of Guangzhou Medical University
Non Small Cell Lung Cancer
Start: 2019-09-01
End: 2034-11-01
Target: 11
Updated: 2024-06-25
Phase 1
Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer
NCT04153799
Sun Yat-sen University
Non Small Cell Lung Cancer
Start: 2019-11-01
End: 2022-12-31
Target: 11
Updated: 2020-05-12
Related Papers
Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy.
2021-02-15
6 citations